Logo image of HCVI

HENNESSY CAPITAL INVEST-CL A (HCVI) Stock Fundamental Analysis

NASDAQ:HCVI - Nasdaq - US42600H1086 - Common Stock - Currency: USD

11.67  +0.82 (+7.56%)

After market: 10.11 -1.56 (-13.37%)

Fundamental Rating

0

Overall HCVI gets a fundamental rating of 0 out of 10. We evaluated HCVI against 0 industry peers in the Unkown industry. Both the profitability and financial health of HCVI have multiple concerns. HCVI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HCVI has reported negative net income.
HCVI had a negative operating cash flow in the past year.
HCVI Yearly Net Income VS EBIT VS OCF VS FCFHCVI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M 10M 15M

1.2 Ratios

Industry RankSector Rank
ROA -28.41%
ROE -100.95%
ROIC N/A
ROA(3y)2.51%
ROA(5y)N/A
ROE(3y)2.61%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HCVI Yearly ROA, ROE, ROICHCVI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 2 4

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HCVI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HCVI Yearly Profit, Operating, Gross MarginsHCVI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, HCVI has less shares outstanding
The debt/assets ratio for HCVI is higher compared to a year ago.
HCVI Yearly Shares OutstandingHCVI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M 40M
HCVI Yearly Total Debt VS Total AssetsHCVI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 1.04, we must say that HCVI is in the distress zone and has some risk of bankruptcy.
HCVI has a Debt/Equity ratio of 0.61. This is a neutral value indicating HCVI is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Altman-Z 1.04
ROIC/WACCN/A
WACCN/A
HCVI Yearly LT Debt VS Equity VS FCFHCVI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.56 indicates that HCVI may have some problems paying its short term obligations.
HCVI has a Quick Ratio of 0.56. This is a bad value and indicates that HCVI is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.56
HCVI Yearly Current Assets VS Current LiabilitesHCVI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for HCVI have decreased strongly by -878.08% in the last year.
EPS 1Y (TTM)-878.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11000%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HCVI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCVI Price Earnings VS Forward Price EarningsHCVI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HCVI Per share dataHCVI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HCVI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HENNESSY CAPITAL INVEST-CL A

NASDAQ:HCVI (4/3/2025, 8:00:01 PM)

After market: 10.11 -1.56 (-13.37%)

11.67

+0.82 (+7.56%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners89.47%
Inst Owner Change-16.62%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap170.85M
AnalystsN/A
Price TargetN/A
Short Float %0.11%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 10.52
P/tB 10.52
EV/EBITDA N/A
EPS(TTM)-1.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0
BVpS1.11
TBVpS1.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.41%
ROE -100.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)2.51%
ROA(5y)N/A
ROE(3y)2.61%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.56
Altman-Z 1.04
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-878.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11000%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-68.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.79%
OCF growth 3YN/A
OCF growth 5YN/A